scispace - formally typeset
hero-background
Mary Ann Liebert logo

Mary Ann Liebert Publication Guide

Mary Ann Liebert, Inc. is a specialty biomedical and biotechnology publisher founded in 1980 in New Rochelle, New York, known for pioneering niche fields larger publishers overlooked - from gene therapy and tissue engineering to neurotrauma and cannabis research. In December 2024 the company was acquired by Sage, and its roughly 90 peer-reviewed journals continue to publish under the Mary Ann Liebert name.

Journals published: ~90 peer-reviewed specialty titles
Open access options: ~20+ fully-OA titles (incl. the 'Reports' family) + hybrid OA on most subscription journals
APC range: ~$1,250 - $3,000 for fully-OA titles (e.g., Palliative Medicine Reports ~$1,250; Women's Health Reports ~$3,000); hybrid fees vary by journal
Ownership: Part of Sage since December 2024; journals keep the Mary Ann Liebert name
Headquarters: New Rochelle, New York, USA
Transformative Agreements: Yes - Liebert titles are folding into Sage's read-and-publish agreements; check your library
Indexing: Flagship titles indexed in PubMed/MEDLINE, Scopus, and Web of Science
JOURNAL TEMPLATES

Start Writing with Templates

Everything you need to check a manuscript for AI — sentence-level detail, academic-tuned accuracy, and coverage of the latest models.

Publication Guide

Mary Ann Liebert, Inc. has been a fixture of specialty biomedical publishing since 1980, when its founder - one of the few women to build an academic publishing house from scratch - launched the company in New Rochelle, New York. Its first title, the Journal of Interferon Research, appeared in 1981, and the strategy has stayed consistent ever since: find emerging niches that larger publishers overlook and build the field's journal of record. That approach produced early journals in genetic engineering, gene therapy, tissue engineering, telemedicine, and more recently cannabis science and CRISPR research.

In December 2024 Sage acquired Mary Ann Liebert, Inc. The roughly 90 peer-reviewed journals continue to publish under the Mary Ann Liebert name as part of Sage, and the journal platform has moved to Sage's infrastructure (liebertpub.com now resolves to the Sage Journals site). This guide covers what that means for authors in 2026: choosing a journal, open-access options and APCs, peer review, and how to submit.

Which Mary Ann Liebert journal fits your paper?

Liebert's portfolio is narrow but deep - most titles are the leading or founding journal of a specific biomedical niche. Use the routes below to shortlist.

You're most likely to...Choose this route
Have clinical or translational neuroscience trauma researchJournal of Neurotrauma - the field's core title; Neurotrauma Reports is its fully-OA companion (~$1,750 APC).
Work on gene or cell therapyHuman Gene Therapy family - research, methods, and clinical development sections.
Work in redox biology or free-radical researchAntioxidants & Redox Signaling - among the highest-cited Liebert titles.
Study HIV/AIDS virology or epidemiologyAIDS Research and Human Retroviruses - one of Liebert's longest-running flagships.
Do regenerative medicine or biomaterials workTissue Engineering (Parts A, B, and C cover research, reviews, and methods).
Have thyroid, endocrine, or palliative-care clinical researchThyroid (official ATA journal) or Journal of Palliative Medicine; both have OA 'Reports' companions.
Need a fully open-access venue with a modest APCThe 'Reports' family - Neurotrauma Reports, Palliative Medicine Reports, Women's Health Reports, Telemedicine Reports, Integrative Medicine Reports (~1,2501,250 - 3,000).
Work on cannabis science or space/life sciencesCannabis and Cannabinoid Research or Astrobiology - both field-defining Liebert titles.

What Mary Ann Liebert actually publishes

~90 peer-reviewed journals, concentrated in biomedicine and biotechnology:

  • Biomedical research and clinical medicine - AIDS Research and Human Retroviruses, Journal of Neurotrauma, Thyroid, Journal of Palliative Medicine, Journal of Women's Health, Surgical Infections.
  • Biotechnology and life-science methods - Human Gene Therapy, Tissue Engineering, The CRISPR Journal (launched 2018), Assay and Drug Development Technologies, OMICS: A Journal of Integrative Biology.
  • Emerging and interdisciplinary fields - Cannabis and Cannabinoid Research, Big Data, Telemedicine and e-Health, Astrobiology, Games for Health Journal.
  • The fully-OA 'Reports' family - Gold OA companions to established titles, including Neurotrauma Reports, Palliative Medicine Reports, Women's Health Reports, Telemedicine Reports, and Integrative Medicine Reports.

Open access and APCs

Mary Ann Liebert offers three OA routes, now administered through Sage:

  • Gold OA (fully-OA journals) - roughly 20+ titles, led by the 'Reports' family, published under CC BY licenses.
  • Hybrid OA - most legacy subscription titles offer an OA option per article; fees vary by journal, so check the journal's for-authors page.
  • Green OA (self-archiving) - permitted; deposit terms follow the journal's policy, now aligned with Sage's author archiving rules.

Verified 2026 APC anchors for fully-OA titles (USD, before tax - always confirm on the journal's current price page):

JournalAPC
Palliative Medicine Reports~$1,250
Integrative Medicine Reports~$1,450
Neurotrauma Reports~$1,750
Telemedicine Reports~$2,500
Women's Health Reports~$3,000

Waivers and discounts are available on request for authors who lack funding, and Liebert titles are progressively being added to Sage's read-and-publish (transformative) agreements - check the ESAC registry or ask your library whether your institution's Sage deal covers Liebert journals. Note that cOAlition S ended the Transformative Journal framework at the end of 2024, so OA-funding compliance now runs mainly through institutional agreements.

Peer review process

  • Default model: single-anonymized peer review across most titles.
  • Editorial structure: journals are editor-led with field-specialist boards; many titles are official journals of societies (e.g., Thyroid for the American Thyroid Association).
  • Turnaround: varies by journal; specialty titles typically return a first decision in one to three months. Check the journal's page for current averages.

How to submit

  1. Pick the journal. Browse the Liebert portfolio on the Sage platform or use SciSpace journal pages to compare scope and metrics.
  2. Read the manuscript-preparation guide. Each title has its own instructions; most use Vancouver-style referencing.
  3. Prepare your manuscript. Liebert journal templates are available on SciSpace to match each title's format requirements.
  4. Submit online. Most Liebert titles have used ScholarOne Manuscripts; following the Sage acquisition, some journals are migrating to Sage's submission systems - the journal's author-instructions page tells you which portal to use.
  5. Track and revise. Status updates, reviewer reports, and revisions are handled in the same portal.

Ethics and integrity

Mary Ann Liebert is a member of COPE and OASPA, and its titles follow COPE guidelines on authorship, corrections, and retractions. As part of Sage, Liebert journals also fall under Sage's research-integrity policies, including image-integrity screening and data-availability statements on many titles. Predatory-risk assessments consistently rate Liebert as an established, legitimate specialty publisher.

SCISPACE FOR ACADEMIC PUBLISHING

SciSpace AI Agent Helps 10 Mn+ Researchers Get Publish Ready

Researchers worldwide trust SciSpace AI Detector to uphold academic integrity and support honest, original work.

"SciSpace AI Detector has completely changed how I review student submissions. The sentence-level breakdown makes it easy to have honest, evidence-based conversations."

SM

Dr. Sarah Mitchell

Cambridge

"The accuracy is unmatched. I've tried other tools, but SciSpace consistently gives me the most reliable results — and the reports are clear enough to share directly with students"

JC

Prof. James Chen

Stanford University

"What I love most is how easy it is to use. My whole department adopted it within a week. It's now a core part of how we evaluate submitted work across all courses."

ER

Dr. Emily Rodriguez

University of Texas

PUBLISHER COMPARISON

How Mary Ann Liebert compares

How Mary Ann Liebert compares across breadth of titles, open-access routes, APCs, waivers and turnaround.

Mary Ann Liebert
Mary Ann Liebert logo
How Mary Ann Liebert compares across breadth of titles, open-access routes, APCs, waivers and turnaround.
Karger Publishers
Karger Publishers logo
How Karger compares across breadth of titles, open-access routes, APCs, waivers and turnaround.
Thieme Group
Thieme Group logo
How Thieme compares across breadth of titles, open-access routes, APCs, waivers and turnaround.
Wolters Kluwer Health (Lippincott)
Wolters Kluwer Health (Lippincott) logo
How Wolters Kluwer Health compares across breadth of titles, open-access routes, APCs, waivers and turnaround.
Core Features
Best for
Niche biomedical & biotech fields: gene therapy, tissue engineering, neurotrauma, thyroid, cannabis research
Clinical specialty medicine - long-established niche journals across nearly every medical specialty
Synthetic organic chemistry (Synthesis, Synlett), clinical medicine, and surgical specialties
Clinical medicine, nursing, and society flagship journals (Circulation, Neurology, JCO)
Typical APC (OA)
~$1,250 - $3,000 (fully-OA titles); hybrid varies by journal
~$1,500 - $4,500
~$1,500 - $4,000
~$1,000 - $2,250 fully-OA; ~$3,000 - $5,000+ hybrid
LMIC fee waivers
Yes - waivers and discounts available on request for eligible authors
Yes - waivers and discounts for authors from low-income countries
Yes - waiver policy for eligible authors; contact oa-support@thieme.com
Yes - Research4Life-based tiers: full waivers plus 50% discounts by country
Read & Publish deals coverage
Growing - Liebert titles are being added to Sage's TA portfolio; check ESAC or your library
Yes - agreements with consortia incl. Switzerland, Germany, Australia (CAUL) and others
Growing - agreements with Jisc (UK) and other consortia in the ESAC registry
Growing - agreements with Jisc (UK), Stanford, and other institutions/consortia
Free / subscription (non-OA option)
Yes - most legacy Liebert titles are subscription/hybrid
Yes - most Karger titles remain subscription journals with no mandatory fee
Yes - most Thieme journals are subscription-based with no publication fee
Yes - most society journals remain subscription-based
Breadth of titles
~90 specialty journals, mostly biomedical and biotech
~100 journals, medicine and biomedical only
~150 journals across medicine, chemistry, and nursing
300+ Lippincott journals; ~500 incl. Medknow; medicine, nursing, allied health
Cheapest realistic OA route
The 'Reports' OA family - e.g., Palliative Medicine Reports ~$1,250, Neurotrauma Reports ~$1,750
Case-report and smaller Gold OA titles from ~$1,500-$2,500 (varies by title)
Smaller Thieme Open fully-OA titles from ~$1,500 (varies by journal)
Medknow society titles (many low- or no-APC) or fully-OA Lippincott from ~$1,000
Speed to first decision
Varies by title - check each journal's page; specialty titles typically 1-3 months
Varies by title - clinical specialty journals typically 1-3 months to first decision
Varies by title - chemistry titles are known for fast handling; check each journal page
Varies by society journal; flagship clinical titles typically 4-12 weeks
KEY BRANDS

Mary Ann Liebert Journal Family

The most popular Mary Ann Liebert journals, each linked to its SciSpace journal page with metrics, templates, and submission details.

SciSpace AI Agent for researchers

Write your Manuscript Faster with SciSpace AI Agent

Beyond AI detection, SciSpace gives teachers and researchers access to powerful AI agents for every academic task.

10M+ researchers use SciSpace for research
Harvard UniversityJohns Hopkins UniversityStanford UniversityUniversity of CambridgeYale University
Faqs

Mary Ann Liebert FAQs

Mary Ann Liebert, Inc. is a specialty biomedical and biotechnology publisher founded in 1980 in New Rochelle, New York. It publishes roughly 90 peer-reviewed journals in niche fields such as gene therapy, tissue engineering, neurotrauma, and cannabis research. Since December 2024 it has been part of Sage, publishing under the Mary Ann Liebert name.